Project Grant K99DE035208
Award Date 8/6/26
Completion Date 7/31/28
Dollars Obligated $136K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
- The National Institute of Dental and Craniofacial Research awarded the University of Illinois $576,957 on September 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and evaluate nanotherapeutic and immunotherapeutic approaches for periodontal disease targeting inflammatory and osteoclastogenic pathways. The project develops site-specific nanoparticle platforms designed to attenuate disease progression and preserve alveolar bone. Aim 1 evaluates myeloid...
- The National Institute of Dental and Craniofacial Research, within the Department of Health and Human Services National Institutes of Health, awarded the University of Illinois $320,660 on July 9, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop anionic nanohybrid aggregate formulations for early childhood caries prevention. The project addresses early childhood caries affecting approximately 25 percent of American preschool children, particularly those of...
- The National Institute of Dental and Craniofacial Research, part of the Department of Health and Human Services National Institutes of Health, awarded the University of Illinois $249,000 on August 5, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop bone-like organoids that elucidate how immune responses influence craniofacial bone healing and regeneration. The recipient will establish bone-like organoids as predictive tools for craniofacial bone repair...
- The National Institute of Dental and Craniofacial Research awarded the University of Illinois $273,014 on March 1, 2030, under the Oral Diseases and Disorders Research program (CFDA 93.121) to support clinician-scientist training and research on NG2/CSPG4 signaling in mandibular endochondral fracture healing. The recipient will conduct laboratory experimentation and professional development to advance understanding of how mechanical loading-dependent NG2/CSPG4 signaling regulates the...
- The National Institute of Dental and Craniofacial Research awarded The University of Iowa $540,583 on August 6, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop an innovative mitochondria-targeted strategy for alveolar bone regeneration in periodontitis. The research, led by PI Sun's group, advances a patent-pending alpha-ketoglutarate-based polymer (PAKG) derived from a key metabolite in the tricarboxylic acid cycle. PAKG nanoparticles are designed to be...
- The National Institute of Dental and Craniofacial Research awarded the University of Illinois $320,660 on April 6, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate the immunoregulatory role of dendritic cell subsets in periodontal disease. The award funds research examining how three major dendritic cell subsets—myeloid, lymphoid, and plasmacytoid dendritic cells—respond during periodontal disease resolution and interact functionally with periopathic...
- The National Institute of Dental and Craniofacial Research awarded The University of Chicago $133,239 on April 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and deliver a research education program called Cultivating Researchers in Oral and Systemic Health Studies (CROSS). The program trains undergraduate students enrolled in colleges across the Chicago area in cross-disciplinary clinical research that integrates oral health, medicine, and the social...
- The National Institute of Dental and Craniofacial Research, part of the Department of Health and Human Services National Institutes of Health, awarded The Washington University $427,625 on February 6, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121). The award funds research to develop and evaluate radiation-guided theranostic agents for detecting and monitoring response to oral cancer treatment. The research leverages radiation-inducible antigens, specifically...
- The National Institute of Dental and Craniofacial Research, part of the National Institutes of Health within the Department of Health and Human Services, awarded $435,875 to Indiana University Indianapolis on July 15, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate oxylipin-mediated biofilm colonization in peri-implant disease. The research explores the role of oxylipins in regulating bacterial biofilm formation around dental implants. The study aims...
- The National Institute of Dental and Craniofacial Research awarded Northwestern University $633,074 under the Oral Diseases and Disorders Research program (CFDA 93.121) on July 1, 2026, to conduct multiscale modeling of enamel dissolution in caries formation. The research addresses how compositional gradients and residual stresses in tooth enamel crystallites influence the dissolution process during caries lesion formation. The project examines the core-shell structure of enamel crystallites,...